Filter
6979
Filtered Results: 6979
Text search:
access
to
medicines
Featured
Recommendations
600
New Publications
1746
Language
Document type
No document type
3775
Studies & Reports
1387
Guidelines
848
Manuals
363
Strategic & Response Plan
263
Fact sheets
119
Training Material
104
Situation Updates
68
Resource Platforms
22
Infographics
13
Brochures
9
Online Courses
6
App
1
Videos
1
Countries / Regions
India
291
Global
283
Kenya
211
South Africa
173
Ethiopia
150
Uganda
139
Nepal
129
Nigeria
126
Sierra Leone
124
Western and Central Europe
124
Latin America and the Carribbean
115
Liberia
112
Africa
111
Tanzania
110
Malawi
103
Bangladesh
97
Zambia
93
Ukraine
91
Myanmar / Burma
89
Syria
84
Rwanda
81
Ghana
80
Congo, Democratic Republic of
58
Philippines
54
Zimbabwe
53
South–East Asia Region
50
Eastern Europe
50
Venezuela
48
Namibia
48
Mozambique
45
Asia
41
Lesotho
37
East and Southern Africa
36
West and Central Africa
35
Brazil
35
Senegal
34
Cambodia
34
Yemen
33
Guinea
32
Haiti
32
South Sudan
32
Russia
30
Colombia
28
Cameroon
27
Germany
26
Middle East and North Africa
26
Indonesia
26
Burkina Faso
24
Botswana
24
Benin
19
Afghanistan
19
Eswatini/ Swaziland
19
Eastern Europe and Central Asia
18
Pakistan
18
Thailand
16
Sudan
16
Peru
15
Vietnam
15
USA
14
Lebanon
14
Moldova
13
Somalia
13
Tajikistan
12
Jordan
12
Bolivia
12
China
11
Western Pacific Region
11
North America
11
Sri Lanka
11
Mali
11
Paraguay
10
Georgia
10
Central African Republic
10
Ecuador
10
Albania
9
North Macedonia
8
Mexico
8
Chile
8
Laos
8
Argentina
8
Iraq
8
Madagascar
8
El Salvador
7
Turkey
7
Southern Africa
7
Palestine
7
Poland
6
Kazakhstan
5
Iran
5
Kyrgyzstan
5
Jamaica
5
United Kingdom
5
Spain
5
Côte d’Ivoire / Ivory Coast
5
Egypt
5
Canada
4
Burundi
4
Hungary
4
Saudi Arabia
4
Turkmenistan
4
Papua New Guinea
4
Romania
4
Libya
4
Timor Leste/ East Timor
3
Serbia
3
Gambia
3
Togo
3
Niger
3
Uzbekistan
3
Armenia
3
Portugal
3
Belarus
3
Greece
3
Chad
3
Guatemala
3
Switzerland
2
Estonia
2
Malaysia
2
Morocco
2
Qatar
2
Bulgaria
2
Lithuania
2
Japan
2
France
2
Mauritius
2
Bosnia and Herzegovina
2
Nicaragua
2
Angola
2
Bhutan
2
Australia
1
Fiji
1
Singapore
1
Congo-Brazzaville
1
Austria
1
Mongolia
1
Mauritania
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Gabon
1
Uruguay
1
Denmark
1
Maldives
1
Tunisia
1
Norway
1
South Korea
1
French Guyana
1
Israel
1
Djibouti
1
Slovakia
1
Honduras
1
Authors & Publishers
Publication Years
Category
Countries
2585
Clinical Guidelines
548
Public Health
417
Women & Child Health
315
Key Resources
302
Capacity Building
119
Pharmacy & Technologies
76
Annual Report MEDBOX
3
Toolboxes
HIV
613
COVID-19
562
Mental Health
559
TB
407
AMR
278
NTDs
224
Disability
218
Caregiver
212
Planetary Health
204
Conflict
186
Pharmacy
180
NCDs
172
Ebola & Marburg
170
Rapid Response
147
Global Health Education
118
Refugee
114
Health Financing Toolbox
81
Natural Hazards
68
Zika
36
Social Ethics
29
Specific Hazards
26
Cholera
26
Polio
17
Malaria
12
Typhoon
1
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th...
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatment of chronic noncommunicable diseases. The evaluation combines both quantitative and qualitative anal...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement...
Nearly 90 years after Simon Kuznets first introduced Gross Domestic Product (GDP) for the limited purpose of measuring economic growth (by measuring the monetary value of all local goods and services within a given period of time), calls continue to mount for decision-makers to stop using GDP and it...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare level. This document includes treatment protocols ...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...
The GEHM series is an evidence-informed normative product of the WHO
Health and Migration Programme to inform policy-makers on migrationrelated public health priorities. These reviews aim to respond to policy questions identified as priorities by summarizing the best available evidence worldwide an...
The shortage of human resources for health, and in particular physicians, is one of the major barriers to achieve universal access to HIV care and treatment. In September 2005, a pilot program of nurse-centered antiretroviral treatment (ART) prescription was launched in three rural primary health ce...
The Emergency Access Initiative (EAI) has been activated in support of medical efforts related to the Ebola Outbreak in West Africa. The Emergency Access Initiative is a col-
laborative partnership between the U.S. National Library of Medicine and participating publishers to provide free access to ...
In 2018, approximately 60,000 Ugandans were estimated to be suffering from cancer. It was also reported that only 5% of cancer patients access cancer care and 77% present with late-stage cancer coupled with low level of cancer health literacy in the population despite a wide coverage of primary heal...
More than 40% of the world population is 24 years old or younger, the vast majority of whom live in low- and lower middle–income countries. Globally, a quarter of disability-adjusted life years (DALYs) for mental disorders and substance abuse is borne by this age group and about 75% of mental diso...
